Related Experiment Video
Updated: Aug 2, 2026

Analysis of Cell Cycle Position in Mammalian Cells
Published on: January 21, 2012
The physiology of p16(INK4A)-mediated G1 proliferative arrest
G I Shapiro1, C D Edwards, B J Rollins
1Department of Adult Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02115, USA.
Abstract:
Phosphorylation of the product of the retinoblastoma susceptibility gene (Rb) physiologically inactivates its growth-suppressive properties. Rb phosphorylation is mediated by cyclin-dependent kinases (CDKs), whose activity is enhanced by cyclins and inhibited by CDK inhibitors. p16(INK4A) is a member of a family of inhibitors specific for CDK4 and CDK6. p16(INK4A) is deleted and inactivated in a wide variety of human malignancies, including familial melanomas and pancreatic carcinoma syndromes, indicating that it is an authentic human tumor suppressor. Although one mechanism for its tumor suppression may be prevention of Rb phosphorylation, thereby causing G1 arrest, many normal cell types express p16(INK4A), and are still able to traverse the cell cycle. In a search for other mechanisms, we have found that p16(INK4A) is required for p53-independent G1 arrest in response to DNA-damaging agents, including topoisomerase I and II inhibitors. Thus, like other tumor suppressors, p16(INK4A) plays an essential role in a DNA-damage checkpoint that leads to cell cycle arrest.
Insights
The retinoblastoma protein (Rb) normally suppresses cell growth, but phosphorylation inactivates it. The p16(INK4A) protein, a tumor suppressor, is crucial for DNA damage checkpoints, inducing cell cycle arrest independently of p53.
Area of Science:
- Molecular Biology
- Cell Cycle Regulation
- Oncology
Background:
- Phosphorylation of the retinoblastoma protein (Rb) inactivates its growth-suppressive function.
- Cyclin-dependent kinases (CDKs) mediate Rb phosphorylation, with activity regulated by cyclins and CDK inhibitors.
- p16(INK4A) is a specific inhibitor of CDK4 and CDK6, recognized as a tumor suppressor due to its frequent inactivation in human cancers.
Purpose of the Study:
- To investigate the mechanisms by which p16(INK4A) functions as a tumor suppressor.
- To explore alternative pathways for p16(INK4A)-mediated tumor suppression beyond Rb phosphorylation.
- To determine the role of p16(INK4A) in cellular responses to DNA damage.
Main Methods:
- Analysis of p16(INK4A) function in cell cycle regulation.
- Investigation of p16(INK4A) involvement in DNA-damage response pathways.
- Assessment of p53-independent cell cycle arrest mechanisms.
Main Results:
- p16(INK4A) is essential for p53-independent G1 arrest in response to DNA-damaging agents like topoisomerase inhibitors.
- While p16(INK4A) can prevent Rb phosphorylation, its role in DNA-damage-induced cell cycle arrest is independent of this mechanism.
- Many normal cells expressing p16(INK4A) can still proliferate, suggesting additional functions.
Conclusions:
- p16(INK4A) functions as a critical component of the DNA-damage checkpoint, inducing cell cycle arrest.
- This DNA-damage response mediated by p16(INK4A) is p53-independent.
- p16(INK4A) plays a vital role in maintaining genomic stability by facilitating cell cycle arrest following DNA damage.
More Related Videos
Related Concept Videos
Negative Regulator Molecules
DNA Damage can Stall the Cell Cycle
Inhibition of Cdk Activity
Abnormal Proliferation
DNA Damage Can Stall the Cell Cycle
Molecular Factors Affecting Cell Division
Several proteins function as internal regulators to ensure each cell cycle stage is completed faithfully before proceeding to the next. Regulator molecules may act directly or influence the activity or production of other...

